“a parallel, randomised, open-label clinical trial evaluating the safety and efficacy of methotrexate with apremilast in patients with moderate to severe palmoplantar psoriasis”., Int. J. Pharm. Sci. Lett., vol. 11, no. 2, pp. 1–11, Apr. 2021, Accessed: May 11, 2026. [Online]. Available: https://ijpsl.org/index.php/ijpls/article/view/21